RESULTS FOR : 'Immunotherapy'
Showing 1 to 4 of 4 results |    
Keyword Search
Show#
Show#
Results Category/Section
Monitoring the balance between immune repression and stimulation in cancer immunotherapy

Cancer is still one of the main causes of death worldwide, yet recent strides towards more effective treatments have been made in the form of new cancer immunotherapies.

The use of syngeneic models for the discovery of targets for combination therapy and predictive biomarkers of immunotherapy efficacy.

Optimal treatment for any disease is one that can cure or prevent spreading with minimal impact on the patient’s quality of life. In the case of cancer, therapeutic agents were initially designed to kill rapidly dividing cells.

Anti-infective immunotherapy for treating hospital acquired infections.

The frequency of nosocomial (acquired in healthcare facility) pneumonia has experienced a steady increase in recent years, and treatment of these infections has become more challenging and expensive due to the emergence of multi-drug resistant bacterial strains.

Immunotherapeutics: the coming of age of cancer immunotherapy as a treatment paradigm.

As the oncology drug development landscape has evolved, so too have the processes, methods and equipment used in the fight against cancer. Traditional treatments such as chemotherapy and radiation therapy are still very popular and remain effective methods of fighting the disease as a whole.